Substantial Equivalence is a regulatory framework used to assess new products, particularly genetically modified organisms, by comparing them to existing, conventionally produced counterparts deemed safe. If a new product is found to be substantially equivalent to an existing one, it typically requires fewer safety assessments before approval.